New Frontier Health Corporation Ordinary Shares
NFH was delisted on the 26th of January, 2022.
34 hedge funds and large institutions have $436M invested in New Frontier Health Corporation Ordinary Shares in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 3 closing their positions.
140% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 5
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
13% more funds holding
Funds holding: 30 → 34 (+4)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
7% less capital invested
Capital invested by funds: $469M → $436M (-$33.3M)
Top Buyers
Top Sellers
NFH Hedge Fund Activity: Q4 2020 in Review
34 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in New Frontier Health Corporation Ordinary Shares (NFH) for Q4 2020, worth a combined $436M — down 7.1% from $469M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NFH positions and 3 closed out — a net gain of 4 holders — while 12 added to existing stakes and 5 trimmed.
The largest buyer was Oasis Management Company, adding an estimated $4.81M. The largest seller was Segantii Capital Management, exiting entirely with an estimated $11.7M sold.
- 34 institutional investors held New Frontier Health Corporation Ordinary Shares (NFH) as of Q4 2020, up from 30 in Q3 2020.
- Funds reported $436M of New Frontier Health Corporation Ordinary Shares stock for Q4 2020, down 7.1% quarter-over-quarter.
- 7 funds opened new New Frontier Health Corporation Ordinary Shares positions in Q4 2020 and 3 closed out, a net change of +4 holders.
- The largest New Frontier Health Corporation Ordinary Shares buyer in Q4 2020 was Oasis Management Company, an estimated $4.81M added.
- The largest New Frontier Health Corporation Ordinary Shares seller in Q4 2020 was Segantii Capital Management, an estimated $11.7M sold.
Based on aggregated 13F filings for Q4 2020.